Rare loss-of-function mutations of PTGIR are enriched in fibromuscular dysplasia
- PMID: 32531060
- PMCID: PMC7983006
- DOI: 10.1093/cvr/cvaa161
Rare loss-of-function mutations of PTGIR are enriched in fibromuscular dysplasia
Abstract
Aims: Fibromuscular dysplasia (FMD) and spontaneous coronary artery dissection (SCAD) are related, non-atherosclerotic arterial diseases mainly affecting middle-aged women. Little is known about their physiopathological mechanisms. We aimed to identify rare genetic causes to elucidate molecular mechanisms implicated in FMD and SCAD.
Methods and results: We analysed 29 exomes that included familial and sporadic FMD. We identified one rare loss-of-function variant (LoF) (frequencygnomAD = 0.000075) shared by two FMD sisters in the prostaglandin I2 receptor gene (PTGIR), a key player in vascular remodelling. Follow-up was conducted by targeted or Sanger sequencing (1071 FMD and 363 SCAD patients) or lookups in exome (264 FMD) or genome sequences (480 SCAD), all independent and unrelated. It revealed four additional LoF allele carriers, in addition to several rare missense variants, among FMD patients, and two LoF allele carriers among SCAD patients, including one carrying a rare splicing mutation (c.768 + 1C>G). We used burden test to test for enrichment in patients compared to gnomAD controls, which detected a putative enrichment in FMD (PTRAPD = 8 × 10-4), but not a significant enrichment (PTRAPD = 0.12) in SCAD. The biological effects of variants on human prostaclycin receptor (hIP) signalling and protein expression were characterized using transient overexpression in human cells. We confirmed the LoFs (Q163X and P17RfsX6) and one missense (L67P), identified in one FMD and one SCAD patient, to severely impair hIP function in vitro.
Conclusions: Our study shows that rare genetic mutations in PTGIR are enriched among FMD patients and found in SCAD patients, suggesting a role for prostacyclin signalling in non-atherosclerotic stenosis and dissection.
Keywords: Fibromuscular dysplasia; Prostacyclin signalling; Rare loss-of-function variants; Spontaneous coronary artery dissection.
© The Author(s) 2020. Published by Oxford University Press on behalf of the European Society of Cardiology.
Figures
Comment in
-
PTGIR, a susceptibility gene for fibromuscular dysplasia?Cardiovasc Res. 2021 Mar 21;117(4):990-992. doi: 10.1093/cvr/cvaa353. Cardiovasc Res. 2021. PMID: 33394030 No abstract available.
References
-
- Gornik HL, Persu A, Adlam D, Aparicio LS, Azizi M, Boulanger M, Bruno RM, de Leeuw P, Fendrikova-Mahlay N, Froehlich J, Ganesh SK, Gray BH, Jamison C, Januszewicz A, Jeunemaitre X, Kadian-Dodov D, Kim ES, Kovacic JC, Mace P, Morganti A, Sharma A, Southerland AM, Touze E, van der Niepen P, Wang J, Weinberg I, Wilson S, Olin JW, Plouin PF.. First international consensus on the diagnosis and management of fibromuscular dysplasia. Vasc Med 2019;24:164–189. - PubMed
-
- Olin JW, Froehlich J, Gu X, Bacharach JM, Eagle K, Gray BH, Jaff MR, Kim ES, Mace P, Matsumoto AH, McBane RD, Kline-Rogers E, White CJ, Gornik HL.. The United States Registry for fibromuscular dysplasia: results in the first 447 patients. Circulation 2012;125:3182–3190. - PubMed
-
- Stanley JC, Gewertz BL, Bove EL, Sottiurai V, Fry WJ.. Arterial fibrodysplasia. Histopathologic character and current etiologic concepts. Arch Surg 1975;110:561–566. - PubMed
-
- Luscher TF, Lie JT, Stanson AW, Houser OW, Hollier LH, Sheps SG.. Arterial fibromuscular dysplasia. Mayo Clin Proc 1987;62:931–952. - PubMed
Publication types
MeSH terms
Substances
Supplementary concepts
Grants and funding
- UL1 RR024989/RR/NCRR NIH HHS/United States
- UL1 TR002548/TR/NCATS NIH HHS/United States
- R01 HL128300/HL/NHLBI NIH HHS/United States
- R01 HL103866/HL/NHLBI NIH HHS/United States
- R01 HL130423/HL/NHLBI NIH HHS/United States
- P01 HL147823/HL/NHLBI NIH HHS/United States
- R01 HL139672/HL/NHLBI NIH HHS/United States
- R01 HL148167/HL/NHLBI NIH HHS/United States
- T32 HL007824/HL/NHLBI NIH HHS/United States
- P01 HL076491/HL/NHLBI NIH HHS/United States
- R01 HL135093/HL/NHLBI NIH HHS/United States
- PG/13/96/30608/BHF_/British Heart Foundation/United Kingdom
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases
